Skip to main content
Livermore
Livermore
ZHEN

Perigon Wealth Management, LLC

SEC CIK
0001575239
Latest filing
Aug 7, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Perigon Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
22,976
Value
$1.25M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Perigon Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,976$1.25M<0.1%+2,910+14.5%AddedHolders
Q1 202620,066$954.5K<0.1%+1,007+5.3%AddedHolders
Q4 202519,059$999.5K<0.1%+367+2.0%AddedHolders
Q3 202518,692$1.21M<0.1%+380+2.1%AddedHolders
Q2 202518,312$890.7K<0.1%+1,538+9.2%AddedHolders
Q1 202516,774$570.8K<0.1%+17+0.1%AddedHolders
Q4 202416,757$675.3K<0.1%+1,717+11.4%AddedHolders
Q3 202415,040$706.6K<0.1%+388+2.6%AddedHolders
Q2 202414,652$791.4K<0.1%−89−0.6%ReducedHolders
Q1 202414,741$1.00M<0.1%−177−1.2%ReducedHolders
Q4 202314,918$933.9K<0.1%+609+4.3%AddedHolders
Q3 202314,309$649.5K<0.1%+2,925+25.7%AddedHolders
Q2 202311,384$639.1K<0.1%−206−1.8%ReducedHolders
Q1 202311,590$524.2K<0.1%−358−3.0%ReducedHolders
Q4 202211,948$485.7K<0.1%−123−1.0%ReducedHolders
Q3 202212,071$789.0K0.1%+186+1.6%AddedHolders
Q2 202211,885$722.0K0.1%+1,356+12.9%AddedHolders
Q1 202210,529$661.0K<0.1%+1,866+21.5%AddedHolders
Q4 20218,663$656.0K<0.1%+1,397+19.2%AddedHolders
Q3 20217,266$813.0K0.1%+450+6.6%AddedHolders
Q2 20216,816$1.10M0.1%+378+5.9%AddedHolders
Q1 20216,438$784.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.